巨子 ICON - 財經股票資訊及專家分析
快訊
資訊
    虛擬市場
    搜尋 股票/指數/編號

    快訊

    資訊

    Check-Cap Ltd

    CHEK
    0.309
    0.000
    0.39%
    最少15分鐘延遲,股票資訊由第三方資訊供應商提供
    ・Check-Cap Ltd - 延遲價格・最後更新於 01/07 7:02
    最高位
    0.315
    最低位
    0.309
    開市價
    --
    前收市價
    0.310
    成交量(千)
    1.20
    成交額(百萬)
    0.00
    買入
    0.301
    賣出
    0.309
    每手股數
    --
    市值(百萬)
    35.98
    市盈率
    --
    息率
    --
    差價
    --
    52週高低
    1.330 - 0.290
    所有資料不保證絕對正確、完整、或實時,僅作為參考使用。投資涉及風險,過往業績並不代表將來表現,作任何投資決定或交易前,閣下應諮詢獨立專業意見。所有內容均不構成投資建議。

    企業資料

    公司名稱
    Check-Cap Ltd
    證券代碼
    CHEK.US
    所屬板塊
    Diagnostics & Research
    公司業務
    Check-Cap Ltd is a clinical-stage medical diagnostics company engaged in the development of an ingestible imaging capsule that utilizes low-dose X-rays for the detection and imaging of colonic polyps and colorectal cancers, or CRC. The company is developing C-Scan, the first capsule-based system for preparation-free, colorectal cancer screening. Its scanning capsule will be swallowed and propelled by natural motility through the gastrointestinal tract and excreted naturally with no need for retrieval for data collection.
    發行量
    96411949
    公司總部
    29 Abba Hushi Avenue, Check-Cap Building, P.O. Box 1271
    公司網址
    https://www.check-cap.com
    公司電郵
    info@check-cap.com
    公司電話
    +972 546706451
    暫無內容

    關於

    Check-Cap Ltd(CHEK.US)所屬的行業板塊為Diagnostics & Research。
    Check-Cap Ltd is a clinical-stage medical diagnostics company engaged in the development of an ingestible imaging capsule that utilizes low-dose X-rays for the detection and imaging of colonic polyps and colorectal cancers, or CRC. The company is developing C-Scan, the first capsule-based system for preparation-free, colorectal cancer screening. Its scanning capsule will be swallowed and propelled by natural motility through the gastrointestinal tract and excreted naturally with no need for retrieval for data collection.
    詳細公司背景可參考: https://www.check-cap.com